Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jop P Mostert

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Radiology|December 7, 2005
Relationships between brain water content and diffusion tensor imaging parameters (apparent diffusion coefficient and fractional anisotropy) in multiple sclerosisPaul E Sijens, Roy Irwan, Jan Hendrik Potze, et al.
European Radiology|April 23, 2005
Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using 1H MR spectroscopy and diffusion tensor imagingPaul E Sijens, Roy Irwan, Jan Hendrik Potze, et al.
Psychiatry Research|November 20, 2008
Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imagingPaul E Sijens, Jop P Mostert, Roy Irwan, et al.
Neurology|August 26, 2021
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple SclerosisMarcus W Koch, Jop P Mostert, Jerry S Wolinsky, et al.
European Radiology|October 14, 2004
Visual stimulation, 1H MR spectroscopy and fMRI of the human visual pathwaysChristine C Boucard, Jop P Mostert, Frans W Cornelissen, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Response to critical appraisal of patient selection methods in MS prevalence studiesCynthia M C Lemmens, Joost W Vanhommerig, Bart J Knottnerus, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2020
Response to letter 'Lymphocyte counts and the risk of COVID-19 in people with MS'Floor C Loonstra, Zoé LE van Kempen, Eva M Strijbis, et al.
Journal of the Neurological Sciences|March 29, 2005
Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapsesJop P Mostert, Geeta S M Ramsaransing, Dorothea J Heersema, et al.
Multiple Sclerosis and Related Disorders|April 24, 2026
Prescriptions and healthcare use in multiple sclerosis patients within general practices in the NetherlandsCynthia M C Lemmens, Joost W Vanhommerig, Bart J Knottnerus, et al.
Multiple Sclerosis and Related Disorders|December 10, 2024
Prevalence and incidence of multiple sclerosis in the NetherlandsCynthia M C Lemmens, Joost W Vanhommerig, Bart J Knottnerus, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Radiology|December 7, 2005
Relationships between brain water content and diffusion tensor imaging parameters (apparent diffusion coefficient and fractional anisotropy) in multiple sclerosisPaul E Sijens, Roy Irwan, Jan Hendrik Potze, et al.
European Radiology|April 23, 2005
Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using 1H MR spectroscopy and diffusion tensor imagingPaul E Sijens, Roy Irwan, Jan Hendrik Potze, et al.
Psychiatry Research|November 20, 2008
Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imagingPaul E Sijens, Jop P Mostert, Roy Irwan, et al.
Neurology|August 26, 2021
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple SclerosisMarcus W Koch, Jop P Mostert, Jerry S Wolinsky, et al.
European Radiology|October 14, 2004
Visual stimulation, 1H MR spectroscopy and fMRI of the human visual pathwaysChristine C Boucard, Jop P Mostert, Frans W Cornelissen, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Response to critical appraisal of patient selection methods in MS prevalence studiesCynthia M C Lemmens, Joost W Vanhommerig, Bart J Knottnerus, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2020
Response to letter 'Lymphocyte counts and the risk of COVID-19 in people with MS'Floor C Loonstra, Zoé LE van Kempen, Eva M Strijbis, et al.
Journal of the Neurological Sciences|March 29, 2005
Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapsesJop P Mostert, Geeta S M Ramsaransing, Dorothea J Heersema, et al.
Multiple Sclerosis and Related Disorders|April 24, 2026
Prescriptions and healthcare use in multiple sclerosis patients within general practices in the NetherlandsCynthia M C Lemmens, Joost W Vanhommerig, Bart J Knottnerus, et al.
Multiple Sclerosis and Related Disorders|December 10, 2024
Prevalence and incidence of multiple sclerosis in the NetherlandsCynthia M C Lemmens, Joost W Vanhommerig, Bart J Knottnerus, et al.
Pageof 3